Home/Filings/4/0001639860-26-000002
4//SEC Filing

Romano Steven J. 4

Accession 0001639860-26-000002

CIK 0001479615other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:15 PM ET

Size

5.7 KB

Accession

0001639860-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Romano Steven J.
EVP and Chief R&D Officer
Transactions
  • Award

    Employee Share Option (Right to Buy)

    2026-01-02+300,000300,000 total
    Exercise: $2.05Exp: 2036-01-02Ordinary Shares (300,000 underlying)
Footnotes (1)
  • [F1]One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.

Issuer

Silence Therapeutics plc

CIK 0001479615

Entity typeother

Related Parties

1
  • filerCIK 0001639860

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:15 PM ET
Size
5.7 KB